PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy

携带TLR3/RIG-I配体Riboxxim的PLGA颗粒疫苗与免疫检查点阻断剂协同作用，可有效发挥抗癌免疫疗法的作用。